Microtubule inhibiting agents include taxanes, vinca alkaloids, epothilones and eribulin mesylate.
These agents either stabilize or destabilize microtubules, which interferes with mitotic function, resulting in a proptosis.
Limited use by primary and acquired resistance.
Adverse events primarily neutropenia and neuropathy.